+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Respiratory Drugs Market Research Reports

From
Cystic Fibrosis Market - Forecasts from 2024 to 2029 - Product Thumbnail Image

Cystic Fibrosis Market - Forecasts from 2024 to 2029

  • Report
  • January 2024
  • 145 Pages
  • Global
From
Caffeine Market Report and Forecast 2024-2032 - Product Thumbnail Image

Caffeine Market Report and Forecast 2024-2032

  • Report
  • December 2024
  • 130 Pages
  • Global
From
From
From
Americas Sleep Apnea Market Forecast to 2030 - Regional Analysis By Type and End User - Product Thumbnail Image

Americas Sleep Apnea Market Forecast to 2030 - Regional Analysis By Type and End User

  • Report
  • August 2023
  • 136 Pages
  • Latin America, North America Latin America, North America
From
Budesonide Inhalation Aerosol Market in Canada - Product Thumbnail Image

Budesonide Inhalation Aerosol Market in Canada

  • Report
  • February 2026
  • 223 Pages
  • Canada
From
Budesonide Inhalation Aerosol Market in China - Product Thumbnail Image

Budesonide Inhalation Aerosol Market in China

  • Report
  • February 2026
  • 232 Pages
  • China
From
Budesonide Inhalation Aerosol Market in India - Product Thumbnail Image

Budesonide Inhalation Aerosol Market in India

  • Report
  • February 2026
  • 225 Pages
  • India
From
From
From
From
From
Loading Indicator

The Respiratory Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs used to treat respiratory diseases. These drugs are used to treat a variety of conditions, including asthma, chronic obstructive pulmonary disease (COPD), and cystic fibrosis. Commonly prescribed respiratory drugs include bronchodilators, corticosteroids, and antibiotics. The Respiratory Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Companies in the market include GlaxoSmithKline, AstraZeneca, Merck & Co., Novartis, and Boehringer Ingelheim. These companies are constantly researching and developing new drugs to treat respiratory diseases, as well as improving existing treatments. Show Less Read more